Figure 1: Upregulated cellular responses to human IL4 after transfection with the Ile50 variant of IL4Rα compared with the Val50 variant a, Cell proliferation by MTT dye assay.

Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

As far as mild disease, sometimes it can be as simple as just good skincare, moisturizing, especially after baths, avoiding irritants, avoiding allergens, realizing that atopic dermatitis can ...

Dupixent is a fully human monoclonal antibody that inhibits the signaling of the IL4 and IL13 pathways ... including certain patients with atopic dermatitis, asthma, CRSwNP, eosinophilic ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...